These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 3288785)
1. [Basic studies and the reference values of cancer associated antigen CA-50]. Yoshioka H; Shitara M; Sakurabayashi I; Kawai T; Suzuki M Rinsho Byori; 1988 Feb; 36(2):171-6. PubMed ID: 3288785 [No Abstract] [Full Text] [Related]
2. [Fundamental studies and reference values of cancer associated antigen NCC-ST-439]. Yoshioka H; Sakurabayashi I; Kawai T; Suzuki M Rinsho Byori; 1987 Nov; 35(11):1233-8. PubMed ID: 3327976 [No Abstract] [Full Text] [Related]
3. [Fundamental studies and the reference values of cancer associated antigen TAG-72 (CA72-4)]. Shitara M; Yoshioka H; Sakurabayashi I; Kawai T; Suzuki M Rinsho Byori; 1988 Oct; 36(10):1177-81. PubMed ID: 3246730 [No Abstract] [Full Text] [Related]
4. [Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (2)]. Ohkura H; Hattori N; Miyazaki I; Sawabu N; Tobe R; Kawai K; Abe O; Ishii M; Kawai T; Kamano T Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1907-12. PubMed ID: 2439021 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of CA 19-9 radioimmunoassay]. Toya D; Takemori Y; Kidani H; Yoneshima M; Hattori N; Sawabu N Gan To Kagaku Ryoho; 1984 Mar; 11(3):509-14. PubMed ID: 6584087 [TBL] [Abstract][Full Text] [Related]
6. [Studies on prostate specific antigen, gamma-seminoprotein (gamma-Sm) as a tumor marker of prostatic cancer]. Kamachi S; Sakurabayashi I; Kawai T Rinsho Byori; 1984 Jul; 32(7):781-5. PubMed ID: 6389940 [No Abstract] [Full Text] [Related]
7. [Clinical evaluation of a cancer antigen, CA 15-3, associated with breast cancer. (I) Modification of its method and reference values]. Sakurabayashi I; Kawai T; Kawaguchi R; Yonezawa M Rinsho Byori; 1986 Jan; 34(1):53-8. PubMed ID: 3457966 [No Abstract] [Full Text] [Related]
8. [Fundamental studies, reference values, and clinical evaluation of abnormal prothrombin PIVKA-II assay using monoclonal antibody (E-1023)]. Sakurabayashi I; Kawai T; Omizo R; Hattori N; Ishii M Rinsho Byori; 1988 Dec; 36(12):1407-12. PubMed ID: 2854864 [No Abstract] [Full Text] [Related]
9. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl Tn antigen: (1). Evaluation of assay conditions and normal values. STN Study Group]. Imura H; Mori T; Ohkura H; Ishii M; Ariyoshi H; Endo J; Kitao M; Takeda I; Kobayashi H; Inoue M Gan To Kagaku Ryoho; 1989 Sep; 16(9):3213-9. PubMed ID: 2782915 [TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of a cancer antigen, CA 125, associated with ovarian cancer. I. Technical investigation and the reference value]. Sakurabayashi I; Kawai T; Suzuki M; Tamada T; Sato K; Yonezawa M Rinsho Byori; 1984 Dec; 32(12):1345-9. PubMed ID: 6597875 [No Abstract] [Full Text] [Related]
11. [CA 19-9 enzyme immunoassay]. Ota H; Odani H; Watanabe H; Satomura Y; Takemori Y; Okai T; Sawabu N; Mai M; Hattori N; Hashimoto T Gan No Rinsho; 1986 Aug; 32(9):993-7. PubMed ID: 3528560 [TBL] [Abstract][Full Text] [Related]
13. [A new carbohydrate antigen CA 19-9 associated with malignancies of digestive system. I. Modification of its method and reference values]. Sakurabayashi I; Kawai T; Yamanaka T; Kimura K; Yagisawa K; Igarashi S; Yonezawa M; Ioku A Rinsho Byori; 1984 May; 32(5):539-45. PubMed ID: 6592377 [No Abstract] [Full Text] [Related]
14. [Diagnosis of pancreatic carcinoma using 2 associated monoclonal antibodies]. Yao CZ; Zeng XJ; Wang SZ Zhonghua Wai Ke Za Zhi; 1987 Nov; 25(11):655-8, 670. PubMed ID: 3482539 [No Abstract] [Full Text] [Related]
15. [Basic and clinical studies on "ELSA CA 15-3" kit]. Sakahara H; Endo K; Nakajima K; Koizumi M; Nakashima T; Kawamura Y; Ohta H; Inamoto T; Ozawa K; Torizuka K Kaku Igaku; 1986 Oct; 23(10):1485-90. PubMed ID: 3469451 [No Abstract] [Full Text] [Related]
16. [Clinical investigation of carbohydrate antigen CA-50]. Ishii M; Abe O; Okura H; Okazaki N; Kawai T; Saito Y; Sawabu N; Takamizawa Y; Takeuchi T; Niitani H Gan To Kagaku Ryoho; 1987 Aug; 14(8):2548-55. PubMed ID: 3304170 [TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of NCC-ST-439 antigen assay detected by the monoclonal antibody as a tumor marker]. Sugano K; Okura H Nihon Rinsho; 1990 Feb; 48 Suppl():1031-4. PubMed ID: 2192105 [No Abstract] [Full Text] [Related]
18. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma]. Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of CA 15-3 radioimmunoassay]. Takemori Y; Odani H; Watanabe H; Ohta H; Satomura Y; Okai T; Sawabu N; Mai M; Hattori N; Hashimoto T Gan To Kagaku Ryoho; 1987 Jan; 14(1):114-8. PubMed ID: 3467654 [TBL] [Abstract][Full Text] [Related]
20. [Fundamental and clinical evaluation of immunoradiometric assay (IRMA) for serum pancreatic oncofetal antigen (POA)]. Ohba N; Hashimoto T; Nishibu M; Kashiwaya Y; Kawai K; Matsubara F; Miyazaki I Rinsho Byori; 1989 Feb; 37(2):153-8. PubMed ID: 2733181 [No Abstract] [Full Text] [Related] [Next] [New Search]